WCM Investment Management CA boosted its holdings in shares of Core Laboratories N.V. (NYSE:CLB) by 2.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,542,901 shares of the oil and gas company’s stock after purchasing an additional 109,726 shares during the quarter. Core Laboratories N.V. comprises about 5.7% of WCM Investment Management CA’s investment portfolio, making the stock its 9th largest position. WCM Investment Management CA owned about 10.29% of Core Laboratories N.V. worth $448,385,000 at the end of the most recent quarter.
A number of other institutional investors have also added to or reduced their stakes in CLB. Parallel Advisors LLC raised its stake in Core Laboratories N.V. by 13.1% during the second quarter. Parallel Advisors LLC now owns 1,008 shares of the oil and gas company’s stock valued at $101,000 after purchasing an additional 117 shares in the last quarter. The Manufacturers Life Insurance Company increased its position in Core Laboratories N.V. by 63.7% during the second quarter. The Manufacturers Life Insurance Company now owns 1,128 shares of the oil and gas company’s stock valued at $114,000 after acquiring an additional 439 shares during the last quarter. Shine Investment Advisory Services Inc. bought a new position in Core Laboratories N.V. during the second quarter valued at $134,000. Advisory Services Network LLC increased its position in Core Laboratories N.V. by 33.3% during the second quarter. Advisory Services Network LLC now owns 1,365 shares of the oil and gas company’s stock valued at $138,000 after acquiring an additional 341 shares during the last quarter. Finally, First Bank & Trust increased its position in Core Laboratories N.V. by 5.8% during the second quarter. First Bank & Trust now owns 1,493 shares of the oil and gas company’s stock valued at $152,000 after acquiring an additional 82 shares during the last quarter.
CLB has been the topic of a number of analyst reports. Zacks Investment Research cut shares of Core Laboratories N.V. from a “hold” rating to a “strong sell” rating in a research report on Monday, July 17th. Piper Jaffray Companies set a $97.00 price objective on shares of Core Laboratories N.V. and gave the company a “hold” rating in a research report on Wednesday, July 26th. UBS AG reiterated a “neutral” rating and set a $110.00 price objective (down previously from $125.00) on shares of Core Laboratories N.V. in a research report on Wednesday, July 26th. Citigroup Inc. cut their price objective on shares of Core Laboratories N.V. from $102.00 to $100.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 26th. Finally, BidaskClub cut shares of Core Laboratories N.V. from a “hold” rating to a “sell” rating in a research report on Monday, July 31st. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $108.64.
Core Laboratories N.V. (CLB) traded down $1.10 during midday trading on Tuesday, hitting $104.30. 512,000 shares of the stock were exchanged, compared to its average volume of 558,552. The company has a current ratio of 2.18, a quick ratio of 1.81 and a debt-to-equity ratio of 1.53. The company has a market capitalization of $4,653.13, a PE ratio of 57.60 and a beta of 1.57. Core Laboratories N.V. has a 12-month low of $86.55 and a 12-month high of $125.83.
Core Laboratories N.V. (NYSE:CLB) last posted its quarterly earnings results on Monday, October 23rd. The oil and gas company reported $0.48 EPS for the quarter, topping the Zacks’ consensus estimate of $0.44 by $0.04. The firm had revenue of $166.20 million for the quarter, compared to analysts’ expectations of $160.94 million. Core Laboratories N.V. had a net margin of 12.06% and a return on equity of 52.89%. The business’s revenue for the quarter was up 1.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.38 earnings per share. research analysts forecast that Core Laboratories N.V. will post 1.99 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 21st. Investors of record on Friday, October 20th will be paid a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a yield of 2.11%. The ex-dividend date of this dividend is Thursday, October 19th. Core Laboratories N.V.’s dividend payout ratio (DPR) is presently 126.44%.
WARNING: “WCM Investment Management CA Grows Position in Core Laboratories N.V. (CLB)” was first reported by Markets Daily and is the sole property of of Markets Daily. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at https://www.themarketsdaily.com/2017/11/14/wcm-investment-management-ca-grows-position-in-core-laboratories-n-v-clb.html.
Core Laboratories N.V. Company Profile
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.
Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories N.V. (NYSE:CLB).
Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with MarketBeat.com's FREE daily email newsletter.